Search Within

Neeta Pandit-Taskar

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (51)
  2. Meeting Abstract (44)
  3. Review (1)
Groups
  1. Department of Medicine (96)
  2. Molecular Imaging and Therapy Service (96)
  3. Radiology, Department of (96)
  4. Solid Tumor Oncology Division (96)
  5. GSK Faculty (67)
  6. Genitourinary Oncology Service (52)

More Groups

People
  1. Steven Larson (46)
  2. Michael Morris (45)
  3. Joseph O'Donoghue (44)
  4. Jorge Carrasquillo (40)
  5. Howard Scher (32)
  6. Serge Lyashchenko (30)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (8)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Journal of Nuclear Medicine (22)
  3. Clinical Cancer Research (8)
  4. European Journal of Nuclear Medicine and Molecular Imaging (7)
  5. Journal for ImmunoTherapy of Cancer (3)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. Society of Nuclear Medicine (22)
  3. Springer (13)
  4. American Association for Cancer Research (12)
  5. Elsevier Inc. (7)
  6. Biomed Central Ltd (3)

More Publishers

Results (96)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II study of arginine deiminase (ADI-PEG 20) in patients with advanced malignant melanoma (MM)
    Meeting Abstract

    Ott, P. A.; Carvajal, R. D.; Pandit-Taskar, N.; Jungbluth, A. A.; Hoffman, E.; Venhaus, R.; Pan, L.; Old, L.; Pavlick, A. C.; Wolchok, J. D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I/II study of docetaxel and (153)Sm for castrate metastatic prostate cancer (CMPC): Summary of dose-escalation cohorts and first report on the expansion cohort
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Rathkopf, D.; Solit, D.; Carrasquillo, J.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J.; Divgi, C. R.; Slovin, S.; Kelly, W. K.; Rathkopf, D.; Gignac, G. A.; Solit, D.; Schwartz, L.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I study of MORAb-003, a humanized monoclonal antibody against folate receptor alpha, in advanced epithelial ovarian cancer
    Meeting Abstract

    Bell-McGuinn, K. M.; Konner, J. A.; Pandit-Taskar, N.; Larson, S. M.; Gerst, S. R.; VanderEls, N.; Old, L.; Weil, S.; Phillips, M.; Aghajanian, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I study of docetaxel (Tax) and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Solit, D.; Rathkopf, D. E.; Carrasquillo, J. A.; Larson, S. M.; Scher, H. I.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003
    Journal Article

    Smith-Jones, P. M.; Pandit-Taskar, N.; Cao, W.; O'Donoghue, J.; Philips, M. D.; Carrasquillo, J.; Konner, J. A.; Old, L. J.; Larson, S. M.
    Nuclear Medicine and Biology (2008)

    Fulltext@MSK | Save
  • Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: Lesion detectability and dosimetric projections for 90Y radioimmunotherapy
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Morris, M. J.; Wills, E. A.; Schwartz, L. H.; Gonen, M.; Scher, H. I.; Larson, S. M.; Divgi, C. R.
    Journal of Nuclear Medicine (2008)

    Fulltext@MSK | Save
  • Novel tracers and their development for the imaging of metastatic prostate cancer
    Journal Article

    Apolo, A. B.; Pandit-Taskar, N.; Morris, M. J.
    Journal of Nuclear Medicine (2008)

    Fulltext@MSK | Save
  • Phase I study of docetaxel and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Amodio, A. J.; Gignac, G. A.; Flatts, E.; Slovin, S.; Solit, D.; Rathkopf, D.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Divgi, C. R.; Bender, S.; O'Donoghue, J. A.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Slovin, S.; Finn, R.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save